Logo image of YHC

LQR HOUSE INC (YHC) Stock Fundamental Analysis

NASDAQ:YHC - Nasdaq - US50215C3079 - Common Stock - Currency: USD

1.46  -0.05 (-3.31%)

After market: 1.44 -0.02 (-1.37%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to YHC. YHC was compared to 96 industry peers in the Media industry. Both the profitability and financial health of YHC have multiple concerns. YHC shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year YHC has reported negative net income.
YHC had a negative operating cash flow in the past year.
YHC Yearly Net Income VS EBIT VS OCF VS FCFYHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

YHC has a worse Return On Assets (-328.22%) than 90.63% of its industry peers.
Industry RankSector Rank
ROA -328.22%
ROE N/A
ROIC N/A
ROA(3y)-167.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YHC Yearly ROA, ROE, ROICYHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for YHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YHC Yearly Profit, Operating, Gross MarginsYHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

YHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YHC has more shares outstanding
YHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
YHC Yearly Shares OutstandingYHC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100K 200K 300K 400K
YHC Yearly Total Debt VS Total AssetsYHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

YHC has an Altman-Z score of -17.14. This is a bad value and indicates that YHC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -17.14, YHC is doing worse than 86.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -17.14
ROIC/WACCN/A
WACC9.1%
YHC Yearly LT Debt VS Equity VS FCFYHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.78 indicates that YHC may have some problems paying its short term obligations.
YHC has a Current ratio of 0.78. This is in the lower half of the industry: YHC underperforms 73.96% of its industry peers.
YHC has a Quick Ratio of 0.78. This is a bad value and indicates that YHC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, YHC is doing worse than 73.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
YHC Yearly Current Assets VS Current LiabilitesYHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for YHC have decreased by -9.01% in the last year.
The Revenue has grown by 123.25% in the past year. This is a very strong growth!
The Revenue has been growing by 99.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.37%
Revenue 1Y (TTM)123.25%
Revenue growth 3Y99.45%
Revenue growth 5YN/A
Sales Q2Q%37.75%

3.2 Future

Based on estimates for the next years, YHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.55% on average per year.
Based on estimates for the next years, YHC will show a very strong growth in Revenue. The Revenue will grow by 194.59% on average per year.
EPS Next Y21.33%
EPS Next 2Y42.2%
EPS Next 3Y29.18%
EPS Next 5Y17.55%
Revenue Next Year72.43%
Revenue Next 2Y194.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YHC Yearly Revenue VS EstimatesYHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
YHC Yearly EPS VS EstimatesYHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YHC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for YHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YHC Price Earnings VS Forward Price EarningsYHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YHC Per share dataYHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

YHC's earnings are expected to grow with 29.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.2%
EPS Next 3Y29.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for YHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LQR HOUSE INC

NASDAQ:YHC (5/20/2025, 8:00:02 PM)

After market: 1.44 -0.02 (-1.37%)

1.46

-0.05 (-3.31%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-14 2024-11-14/dmh
Earnings (Next)N/A N/A
Inst Owners0.79%
Inst Owner ChangeN/A
Ins Owners3.61%
Ins Owner ChangeN/A
Market Cap1.56M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.32%
Min Revenue beat(2)-19.18%
Max Revenue beat(2)6.53%
Revenue beat(4)1
Avg Revenue beat(4)-19.01%
Min Revenue beat(4)-62.94%
Max Revenue beat(4)6.53%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-129.03
EYN/A
EPS(NY)-1.79
Fwd EYN/A
FCF(TTM)-6.19
FCFYN/A
OCF(TTM)-6.19
OCFYN/A
SpS2.34
BVpS-0.48
TBVpS-0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -328.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-167.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z -17.14
F-Score3
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.37%
EPS Next Y21.33%
EPS Next 2Y42.2%
EPS Next 3Y29.18%
EPS Next 5Y17.55%
Revenue 1Y (TTM)123.25%
Revenue growth 3Y99.45%
Revenue growth 5YN/A
Sales Q2Q%37.75%
Revenue Next Year72.43%
Revenue Next 2Y194.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.38%
OCF growth 3YN/A
OCF growth 5YN/A